Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Adjuvant Holdings Co's Enterprise Value is 円3,728 Mil.
Adjuvant Holdings Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was 円171 Mil. Therefore, Adjuvant Holdings Co's EV-to-EBIT ratio for today is 21.84.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Adjuvant Holdings Co's Enterprise Value is 円3,728 Mil.
Adjuvant Holdings Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was 円260 Mil. Therefore, Adjuvant Holdings Co's EV-to-EBITDA ratio for today is 14.32.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Adjuvant Holdings Co (TSE:4929) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Adjuvant Holdings Co's current Enterprise Value is 円3,728 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Adjuvant Holdings Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was 円171 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Adjuvant Holdings Co's current Enterprise Value is 円3,728 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Adjuvant Holdings Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was 円260 Mil.
Adjuvant Holdings Co's current Enterprise Value is 円3,728 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Adjuvant Holdings Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was 円3,814 Mil.
Adjuvant Holdings Co's current Enterprise Value is 円3,728 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Adjuvant Holdings Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was 円133 Mil.
Adjuvant Holdings Co's current Enterprise Value is 円3,728 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Adjuvant Holdings Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was 円90 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adjuvant Holdings Co Enterprise Value Related Terms
Adjuvant Holdings Co Enterprise Value Historical Data
* Premium members only.
The historical data trend for Adjuvant Holdings Co's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4929 vs PG, CL, KVUE: Enterprise Value Comparison
For the Household & Personal Products subindustry, Adjuvant Holdings Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adjuvant Holdings Co Enterprise Value vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Adjuvant Holdings Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Adjuvant Holdings Co's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Adjuvant Holdings Co's Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adjuvant Holdings Co (TSE:4929) has a Enterprise Value of 円3,728 Mil as of Jul. 04, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Adjuvant Holdings Co and its competitors.
Is Adjuvant Holdings Co's Enterprise Value too high?
Adjuvant Holdings Co's current Enterprise Value is 円3,728 Mil. Overall, Adjuvant Holdings Co has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Adjuvant Holdings Co's Enterprise Value compare to PG and CL?
Adjuvant Holdings Co's Enterprise Value of 円3,728 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Consumer Packaged Goods company?
A good Enterprise Value depends on the Consumer Packaged Goods industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Adjuvant Holdings Co and its competitors. Adjuvant Holdings Co's current Enterprise Value is 円3,728 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adjuvant Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Adjuvant Holdings Co (TSE:4929) is currently considered Fairly Valued. The stock's GF Value™ is 円736.10, compared to a current price of 円730.00 — trading 0.8% below its estimated fair value. The current Enterprise Value is 円3,728 Mil. Adjuvant Holdings Co's overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Adjuvant Holdings Co (TSE:4929), the current Enterprise Value is 円3,728 Mil as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Adjuvant Holdings Co (TSE:4929) Overvalued in 2026?
Based on GuruFocus' analysis, Adjuvant Holdings Co stock appears to be undervalued.
The current stock price of 円730.00 is trading 0.8% below its estimated GF Value™ of 円736.10.
GuruFocus considers Adjuvant Holdings Co to be Fairly Valued.
Key valuation signals for TSE:4929:
Enterprise Value: 円3,728 Mil
GF Value™: 円736.10 vs. price of 円730.00 (0.8% below fair value)
No single metric tells the full story. See the TSE:4929 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Adjuvant Holdings Co Ltd, formerly Adjuvant Cosme Japan Co Ltd is engaged in the research, development, production, and sale of cosmetics in Japan. It offers skin care products, including cleansing products, facial cleansers, lotions, beauty essences, masks, moisturizing creams, makeup bases, makeup, and body care products among other products.
63GF Score
Get the complete analysis for TSE:4929
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4929 has been successfully added to your 
